International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function

NM Barnes, GP Ahern, C Becamel, J Bockaert… - Pharmacological …, 2021 - ASPET
5-HT receptors expressed throughout the human body are targets for established
therapeutics and various drugs in development. Their diversity of structure and function …

Analgesic mechanisms of antidepressants for neuropathic pain

H Obata - International journal of molecular sciences, 2017 - mdpi.com
Tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors are used to treat
chronic pain, such as neuropathic pain. Why antidepressants are effective for treatment of …

Neuropathic pain: central vs. peripheral mechanisms

K Meacham, A Shepherd, DP Mohapatra… - Current pain and …, 2017 - Springer
Abstract Purpose of Review Our goal is to examine the processes—both central and
peripheral—that underlie the development of peripherally-induced neuropathic pain (pNP) …

[HTML][HTML] Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review

H Hermanns, MW Hollmann, MF Stevens, P Lirk… - British journal of …, 2019 - Elsevier
Systemic administration of the local anaesthetic lidocaine is antinociceptive in both acute
and chronic pain states, especially in acute postoperative and chronic neuropathic pain …

Multiple modulatory roles of serotonin in chronic pain and injury-related anxiety

S Hao, W Shi, W Liu, QY Chen, M Zhuo - Frontiers in Synaptic …, 2023 - frontiersin.org
Chronic pain is long-lasting pain that often persists during chronic diseases or after recovery
from disease or injury. It often causes serious side effects, such as insomnia, anxiety, or …

Role of 5-HT receptors in neuropathic pain: potential therapeutic implications

QQ Liu, XX Yao, SH Gao, R Li, BJ Li, W Yang… - Pharmacological …, 2020 - Elsevier
HT plays a crucial role in the progress and adjustment of pain both centrally and
peripherally. The therapeutic action of the 5-HT receptorsagonist and antagonist in …

[HTML][HTML] Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

E Rubio-Beltrán, A Labastida-Ramírez… - Pharmacology & …, 2018 - Elsevier
Migraine is a neurovascular disorder that involves activation of the trigeminovascular system
and cranial vasodilation mediated by release of calcitonin gene-related peptide (CGRP) …

What do monoamines do in pain modulation?

K Bannister, AH Dickenson - Current opinion in supportive and …, 2016 - journals.lww.com
The monoaminergic system can be manipulated to great effect in the clinic resulting in
improved treatment outcomes and is the basis for the actions of the antidepressant drugs in …

Crosstalk between intestinal serotonergic system and pattern recognition receptors on the microbiota–gut–brain axis

E Layunta, B Buey, JE Mesonero… - Frontiers in …, 2021 - frontiersin.org
Disruption of the microbiota–gut–brain axis results in a wide range of pathologies that are
affected, from the brain to the intestine. Gut hormones released by enteroendocrine cells to …

Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor

A Levit Kaplan, RT Strachan, JM Braz… - Journal of medicinal …, 2022 - ACS Publications
The 5-HT5A receptor (5-HT5AR), for which no selective agonists and a few antagonists
exist, remains the least understood serotonin receptor. A single commercial antagonist, SB …